Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm
Email ID
Password
Forgotten password?
Sign me in automatically next time
Advanced Search
Home
Product Sector
Regulatory Region
Pre-marketing Regulation
Post-marketing Regulation
Healthcare Systems
Legal
IP
|
Product Liability
|
Competition
|
Legal - IP
Loading IP ....
>> More Ip...
EXPERT VIEW
The EMA's financial juggling act
01 March 2011
Ian Schofield
The European Medicines Agency is in the spotlight this week over the speed with which its former executive director, Thomas Lönngren , took up a post ...
INTERVIEW
Access to Medicines
05 April 1931
UK policy paper published A UK policy paper, entitled Increasing people's access to essential medicines in developing countries: a framework for good ...
Novartis Glivec patent case in India delayed after judge disqualifies himself
08 September 2011
Anju Ghangurde
A Supreme Court judge set to hear a case involving a challenge by Novartis against Section 3d, a controversial provision in India's patent law, has ...
New guidance on regenerative medicinal products launched
08 September 2011
Amanda Maxwell
A new guidance on developing human cells for clinical applications is available 1 . The guidance was issued by the British Standards Institution , ...
US FDA concerned over negotiations schedule for next medtech user fee programme
08 September 2011
Vibha Sharma
The US Food and Drug Administration has expressed concern over the protracted negotiations it is having with the medtech industry over reauthorising ...
US FDA announces training programmes for device review staff
08 September 2011
Vibha Sharma
The US Food and Drug Administration is introducing two new training programmes to improve the consistency and skill of its medical device unit staff ...
5th Test for the second patch
04 August 2011
Peter Reeves
LATEST FEATURES
Supplementary protection certificates: is a new era beckoning for combination drugs in the EU?
28 July 2011
Michael Pears and Mike Snodin consider the opinion of an Advocate General of the Court of Justice of the EU on granting supplementary protection ...
Perspectives on Biopharmaceutical Patent Infringement and Drug Development
21 June 2010
Om V Singh warns that research and manufacturing outsourcing can lead to a greater risk of patent infringement. Billions of dollars are invested ...
Counterfeits: Opportunities for MEDICRIME, Challenges for IMPACT
21 June 2010
Alan Chalmers reports that progress was made at a conference on the Council of Europe?s proposed MEDICRIME convention, despite the controversy ...
>> More Latest Features...
MULTIMEDIA
RAJ Devices News Roundup, 11 December 2009
28 July 2011
About Us
Getting Started
Free Trial
Subscribe
Advertise
Guidelines for Authors
Blog
